Adina Iftimi

Economics, Econometrics and FinanceBiochemistry, Genetics and Molecular BiologyMedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy”.

Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.14904

N/A

0.483DataRank · unranked

24 citations

Annelie Johansson, Anna Nordenskjöld, Adina Iftimi, Christina Yau, Gizeh Pérez‐Tenorio +7 more

Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature

International Journal of Cancer(2022)10.1002/ijc.33969

N/A

0.449DataRank · unranked

19 citations

Nancy Yu, Adina Iftimi, Nicholas P. Tobin, Laura van 't Veer, Bo Nordenskjöld +8 more